BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23364516)

  • 1. Assay development for identifying inhibitors of the mycobacterial FadD32 activity.
    Galandrin S; Guillet V; Rane RS; Léger M; N R; Eynard N; Das K; Balganesh TS; Mourey L; Daffé M; Marrakchi H
    J Biomol Screen; 2013 Jun; 18(5):576-87. PubMed ID: 23364516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dual function of the Mycobacterium tuberculosis FadD32 required for mycolic acid biosynthesis.
    Léger M; Gavalda S; Guillet V; van der Rest B; Slama N; Montrozier H; Mourey L; Quémard A; Daffé M; Marrakchi H
    Chem Biol; 2009 May; 16(5):510-9. PubMed ID: 19477415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into Structure-Function Relationships and Inhibition of the Fatty Acyl-AMP Ligase (FadD32) Orthologs from Mycobacteria.
    Guillet V; Galandrin S; Maveyraud L; Ladevèze S; Mariaule V; Bon C; Eynard N; Daffé M; Marrakchi H; Mourey L
    J Biol Chem; 2016 Apr; 291(15):7973-89. PubMed ID: 26900152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth: identification of the carboxylation product and determination of the acyl-CoA carboxylase components.
    Portevin D; de Sousa-D'Auria C; Montrozier H; Houssin C; Stella A; Lanéelle MA; Bardou F; Guilhot C; Daffé M
    J Biol Chem; 2005 Mar; 280(10):8862-74. PubMed ID: 15632194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ser/Thr Phosphorylation Regulates the Fatty Acyl-AMP Ligase Activity of FadD32, an Essential Enzyme in Mycolic Acid Biosynthesis.
    Le NH; Molle V; Eynard N; Miras M; Stella A; Bardou F; Galandrin S; Guillet V; André-Leroux G; Bellinzoni M; Alzari P; Mourey L; Burlet-Schiltz O; Daffé M; Marrakchi H
    J Biol Chem; 2016 Oct; 291(43):22793-22805. PubMed ID: 27590338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the Essential
    Kuhn ML; Alexander E; Minasov G; Page HJ; Warwrzak Z; Shuvalova L; Flores KJ; Wilson DJ; Shi C; Aldrich CC; Anderson WF
    ACS Infect Dis; 2016 Aug; 2(8):579-591. PubMed ID: 27547819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACCase 6 is the essential acetyl-CoA carboxylase involved in fatty acid and mycolic acid biosynthesis in mycobacteria.
    Kurth DG; Gago GM; de la Iglesia A; Bazet Lyonnet B; Lin TW; Morbidoni HR; Tsai SC; Gramajo H
    Microbiology (Reading); 2009 Aug; 155(Pt 8):2664-2675. PubMed ID: 19423629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of FadD32, an enzyme essential for mycolic acid biosynthesis in mycobacteria.
    Li W; Gu S; Fleming J; Bi L
    Sci Rep; 2015 Dec; 5():15493. PubMed ID: 26628098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but not Escherichia coli fabG.
    Parish T; Roberts G; Laval F; Schaeffer M; Daffé M; Duncan K
    J Bacteriol; 2007 May; 189(10):3721-8. PubMed ID: 17337570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis.
    Schaeffer ML; Carson JD; Kallender H; Lonsdale JT
    Tuberculosis (Edinb); 2004; 84(6):353-60. PubMed ID: 15525558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.
    North EJ; Jackson M; Lee RE
    Curr Pharm Des; 2014; 20(27):4357-78. PubMed ID: 24245756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pks13/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis.
    Gavalda S; Léger M; van der Rest B; Stella A; Bardou F; Montrozier H; Chalut C; Burlet-Schiltz O; Marrakchi H; Daffé M; Quémard A
    J Biol Chem; 2009 Jul; 284(29):19255-64. PubMed ID: 19436070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms.
    Portevin D; De Sousa-D'Auria C; Houssin C; Grimaldi C; Chami M; Daffé M; Guilhot C
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):314-9. PubMed ID: 14695899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening, identification, and characterization of mechanistically diverse inhibitors of the Mycobacterium tuberculosis enzyme, pantothenate kinase (CoaA).
    Venkatraman J; Bhat J; Solapure SM; Sandesh J; Sarkar D; Aishwarya S; Mukherjee K; Datta S; Malolanarasimhan K; Bandodkar B; Das KS
    J Biomol Screen; 2012 Mar; 17(3):293-302. PubMed ID: 22086722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis.
    Sacco E; Covarrubias AS; O'Hare HM; Carroll P; Eynard N; Jones TA; Parish T; Daffé M; Bäckbro K; Quémard A
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14628-33. PubMed ID: 17804795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A coupled spectrophotometric assay for l-cysteine:1-D-myo-inosityl 2-amino-2-deoxy-alpha-D-glucopyranoside ligase and its application for inhibitor screening.
    Newton GL; Ta P; Sareen D; Fahey RC
    Anal Biochem; 2006 Jun; 353(2):167-73. PubMed ID: 16674910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors.
    Altaf M; Miller CH; Bellows DS; O'Toole R
    Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
    Goldman RC
    Tuberculosis (Edinb); 2013 Nov; 93(6):569-88. PubMed ID: 24119636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assays, surrogates, and alternative technologies for a TB lead identification program targeting DNA gyrase ATPase.
    Humnabadkar V; Madhavapeddi P; Basavarajappa H; Sheikh MG; Rane R; Basu R; Verma P; Sundaram A; Mukherjee K; de Sousa SM
    J Biomol Screen; 2015 Feb; 20(2):265-74. PubMed ID: 25300873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32.
    Stanley SA; Kawate T; Iwase N; Shimizu M; Clatworthy AE; Kazyanskaya E; Sacchettini JC; Ioerger TR; Siddiqi NA; Minami S; Aquadro JA; Grant SS; Rubin EJ; Hung DT
    Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11565-70. PubMed ID: 23798446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.